Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neurologic Manifestations × Sildenafil Citrate × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 2 Neurologic Manifestations 1 Glioma 1 Glioblastoma 1

Interventions

Bevacizumab 4 Temozolomide 3 Irinotecan 3 Sorafenib 2 pembrolizumab 1 ibrutinib 1 Vorinostat 1 Valproic Acid 1 Therapeutics 1 Thalidomide 1 Surveys and Questionnaires 1 Sildenafil Citrate 1 Radiosurgery 1 Pliability 1 Lenalidomide 1 Laparoscopy 1 Exercise 1 Carboplatin 1 Bendamustine Hydrochloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01817751 2024-07-17

Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma

Virginia Commonwealth University

Phase 2 Completed

47 enrolled 13 charts

Brain Neoplasms, Glioblastoma, Glioma, Neurologic Manifestations

Data powered by HemOnc (CC BY 4.0) Colophon ⚡